Cheatham Jerry A
Known title: Interim CFOCIK: 0002051102
Associated companies
Transaction History
| SON | ▲ Buy | Option Exercise | 1,925 | $0 | 2/21/2026 | View on chart |
| SON | ▼ Sell | Tax Withholding | 687 | $39K | 2/21/2026 | View on chart |
| SON | ▲ Buy | Option Exercise | 315 | $0 | 2/20/2026 | View on chart |
| SON | ▼ Sell | Tax Withholding | 113 | $6K | 2/20/2026 | View on chart |
| SON | ▲ Buy | Grant | 230 | $10K | 2/19/2026 | View on chart |
| SON | ▼ Sell | Tax Withholding | 83 | $4K | 2/19/2026 | View on chart |
| SON | ▲ Buy | Option Exercise | 180 | $0 | 2/13/2026 | View on chart |
| SON | ▼ Sell | Tax Withholding | 65 | $3K | 2/13/2026 | View on chart |
| SON | ▲ Buy | Grant | 2,259 | $100K | 5/7/2025 | View on chart |
| SON | ▲ Buy | Grant | 1,156 | $56K | 2/21/2025 | View on chart |
| SON | ▼ Sell | Tax Withholding | 415 | $20K | 2/21/2025 | View on chart |
| SON | ▲ Buy | Option Exercise | 315 | $0 | 2/20/2025 | View on chart |
| SON | ▼ Sell | Tax Withholding | 113 | $5K | 2/20/2025 | View on chart |
| SON | ▲ Buy | Option Exercise | 174 | $0 | 2/13/2025 | View on chart |
| SON | ▼ Sell | Tax Withholding | 63 | $3K | 2/13/2025 | View on chart |
| SON | ▲ Buy | Option Exercise | 191 | $0 | 2/10/2025 | View on chart |
| SON | ▼ Sell | Tax Withholding | 69 | $3K | 2/10/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS cuts Sonoco price target to $51, maintains Neutral rating
UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.
UBS cuts Sonoco price target to $51, maintains Neutral rating. UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.